5[6]Furberg CD,Psaty BM,Meyer JV.Nifedipine:dose-related increase in mortality in patients with coronary heart disease[J].Circulation,1995,92 (5):1326.
6[7]Poole-Wilson PA,Luben J,Kirwan BA,et al.Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION tri al):randomised controlled trial[J].Lancet,2004,364 (9437):849.
3Sackett D L, Haynes R B, Guyatt G H, et al. Clinical epidemiology: a basic science for clinical medicine[M]. 2nd ed. Boston: Little Brown, 1991.1 - 10.
4Evidence-Based Medicine Working Group. Users' guides to the edical iterature[J]. JAMA, 1993, 270: 2093, 2098.
5Evidence-Based Medicine Working Group. Users' guides to the edical iterature[J]. JAMA, 1994, 271 : 59,389,1615.
6Evidence-Based Medicine Working Group. Users' guides to the edical iterature[J]. JAMA, 1995,272:234.
7Lin Guowei. Clinical epidemiology in China[J]. Chin Med J, 1996, 109(2):113- 115.
8Sackett D L, Richardson W S, Rosenberg W, et al. Evidence-based medicine, how to practice and teach EBM[M]. 2nd ed. London: Church Livingst, 2000.1 - 50.
9ELEANOR Z, ROSANNE M. Doing the fight thing right: Is Evidence - Based Medicine the answer? [J].Annals of Internal Medicine, 1997, 127:91-94.
10CHRISTIAN G. Trial and errors in clinical research[J]. Lancet, 2000, 354: 59.
8LJ Rubin,DB Badesoh,RJ Barst,et al.Boeentan therapy for pulmonary arterial hypertension[J].The New England Journal of Medicine,2002,346(12):896-903.
9Lewis J Rubin.Diagnosis and Management of Pulmonary Arterial Hypertension:ACCP Evidence-Based Clinical Practice Guidelines[J].Chest,2004,126:7-10.
10Wallis RS,Kyambadde P,Johnson JL,et al.A study of the safety,inununology,virology,and microbiology of adjunctive e~nemept in HIV-1-associated tuberculosis[J].AIDS(London),2004,18:257-264.
